iRhythm Technologies, Inc. (IRTC)
Stock Price:
$231.20 USD
-4.63 (-1.96%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
6.67B |
| Revenue (ttm) |
228.19M |
| Net Income (ttm) |
-65.10M |
| Shares Out |
28.86M |
| EPS (ttm) |
-2.46 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 19, 2020 |
| Last Price |
$231.20 |
| Previous Close |
$235.83 |
| Change ($) |
-4.63 |
| Change (%) |
-1.96% |
| Day's Open |
235.83 |
| Day's Range |
226.71 - 238.18 |
| Day's Volume |
289,917 |
| 52-Week Range |
56.24 - 261.05 |
More Stats
| Market Cap |
6.67B |
| Enterprise Value |
6.68B |
| Earnings Date (est) |
Oct 28, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
28.86M |
| Float |
28.52M |
| EPS (basic) |
-2.47 |
| EPS (diluted) |
-2.46 |
| FCF / Share |
-2.18 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
2.90M |
| Short Ratio |
9.49 |
| Short % of Float |
10.17% |
| Beta |
1.73 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
29.24 |
| PB Ratio |
59.70 |
| Revenue |
228.19M |
| Operating Income |
-65.32M |
| Net Income |
-65.10M |
| Free Cash Flow |
-59.18M |
| Net Cash |
-11.97M |
| Net Cash / Share |
-0.41 |
| Gross Margin |
71.02% |
| Operating Margin |
-28.63% |
| Profit Margin |
-28.50% |
| FCF Margin |
-25.93% |
| ROA |
-16.89% |
| ROE |
-78.17% |
| ROIC |
-19.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (11)
| Buy |
9 |
| Overweight |
0 |
| Hold |
2 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$232.78*
(0.68% upside)
Low
200
Current: $231.20
High
260
Target: 232.78
*Average 12-month price target from 9 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Revenue | 215 | 147 | 99.13 | 64.07 | 36.14 | 21.75 |
| Revenue Growth | 45.68% | 48.57% | 54.72% | 77.29% | 66.17% | - |
| Gross Profit | 162 | 108 | 70.93 | 43.19 | 21.44 | 11.16 |
| Operating Income | -54.76 | -45.69 | -27.59 | -15.58 | -21.63 | -14.77 |
| Net Income | -54.57 | -50.38 | -29.74 | -20.90 | -22.80 | -15.83 |
| Shares Outstanding | 25.27 | 23.89 | 22.63 | 5.29 | 1.38 | 1.31 |
| Earnings Per Share | -2.16 | -2.11 | -1.31 | -3.95 | -16.57 | -12.05 |
| Operating Cash Flow | -21.86 | -29.09 | -14.91 | -16.65 | -18.01 | -15.63 |
| Capital Expenditures | -20.46 | -5.18 | -3.56 | -2.76 | -1.79 | -0.54 |
| Free Cash Flow | -42.32 | -34.27 | -18.47 | -19.41 | -19.79 | -16.17 |
| Cash & Equivalents | 141 | 78.34 | 102 | 106 | 25.30 | 8.71 |
| Total Debt | 129 | 34.90 | 33.98 | 32.23 | 30.55 | 6.26 |
| Net Cash / Debt | 11.96 | 43.44 | 68.39 | 73.91 | -5.25 | 2.45 |
| Assets | 306 | 118 | 133 | 138 | 37.87 | 18.51 |
| Liabilities | 171 | 65.39 | 53.57 | 45.59 | 42.40 | 14.04 |
| Book Value | 135 | 52.14 | 79.55 | 92.56 | -102 | -80.54 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
iRhythm Technologies, Inc. |
| Country |
United States |
| Employees |
997 |
| CEO |
Kevin M. King |
Stock Information
| Ticker Symbol |
IRTC |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NASDAQ: IRTC |
| IPO Date |
October 20, 2016 |
Description
iRhythm Technologies, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.